母体系统性红斑狼疮对胎儿和新生儿影响的综述
本综述描述了系统性红斑狼疮(SLE)对母胎健康按孕期的影响,指出约40%的SLE孕妇存在自身抗体经胎盘传递,可导致新生儿狼疮(NL),其心脏表现通常为永久性。SLE孕妇更易发生子痫前期、胎儿生长受限和早产,可能与胎盘形成受影响有关,强调孕前优化及多学科咨询。
要点
- 约40%的SLE孕妇自身抗体经胎盘传递,可致新生儿狼疮。
- NL心脏表现通常永久,包括传导系统及心肌病变。
- SLE孕妇子痫前期、胎儿生长受限和早产风险增加。
核心结论
- SLE影响母胎健康,需孕前优化及多学科管理。
- 约40%SLE孕妇自身抗体经胎盘传递可致新生儿狼疮。
- SLE孕妇子痫前期、胎儿生长受限和早产风险增加。
研究设计与样本
- 综述,描述SLE对母胎健康按孕期的影响。
主要发现
- 约40%SLE孕妇存在自身抗体经胎盘传递。
- 新生儿狼疮心脏表现通常永久,包括传导系统及心肌病变。
- 新生儿狼疮可有短暂皮肤、血液及肝脏表现。
- SLE孕妇更易发生子痫前期、胎儿生长受限和早产。
- 胎盘形成受影响可能解释不良妊娠结局。
临床怎么用
- 孕前及孕期由风湿科、母胎医学、产科和儿科心脏科多学科咨询。
- 筛查和管理抗Ro/La抗体介导的心脏疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Systemic lupus erythematosus (SLE) primarily affects women of childbearing age and is commonly seen in pregnancy. The physiologic and immunologic changes of pregnancy may alter the course of SLE and impact maternal, fetal, and neonatal health. Multidisciplinary counseling before and during pregnancy from rheumatology, maternal fetal medicine, obstetrics, and pediatric cardiology is critical. Transplacental passage of autoantibodies, present in about 40% of women with SLE, can result in neonatal lupus (NL). NL can consist of usually permanent cardiac manifestations, including conduction system and myocardial disease, as well as transient cutaneous, hematologic, and hepatic manifestations. Additionally, women with SLE are more likely to develop adverse pregnancy outcomes such as preeclampsia, fetal growth restriction, and preterm birth, perhaps due to an underlying effect on placentation. This review describes the impact of SLE on maternal and fetal health by trimester, beginning with prepregnancy optimization of maternal health. This is followed by a discussion of NL and the current understanding of the epidemiology and pathophysiology of anti-Ro/La mediated cardiac disease, as well as screening, treatment, and methods for prevention. Finally discussed is the known increase in preeclampsia and fetal growth issues in women with SLE that can lead to iatrogenic preterm delivery.
引用
- Limaye MA, Buyon JP, Cuneo BF, et al. A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn. 2020. PMID: 32282083. doi:10.1002/pd.5709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。